PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients
- Conditions
- Mycobacterium Avium-intracellulare InfectionHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00002140
- Locations
- 🇺🇸
Dr Milton Estes, Mill Valley, California, United States
🇺🇸Santa Clara Valley Med Ctr, San Jose, California, United States
🇺🇸Whitman - Walker Clinic, Washington, District of Columbia, United States
A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems
- Conditions
- Candidiasis, EsophagealHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00002304
- Locations
- 🇺🇸
Eisenhower Med Ctr, Rancho Mirage, California, United States
🇺🇸Univ Hosp, Boston, Massachusetts, United States
🇺🇸Buckley Braffman Stern Med Associates, Philadelphia, Pennsylvania, United States
Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
- Conditions
- Meningitis, CryptococcalHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00002075
- Locations
- 🇺🇸
Dr Robert Larsen, Los Angeles, California, United States
Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome
- Conditions
- Candidiasis, OralHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00002112
- Locations
- 🇺🇸
California Med Research Group, Fresno, California, United States
🇺🇸UCSF Hosp, San Francisco, California, United States
🇺🇸Johns Hopkins School of Medicine, Baltimore, Maryland, United States
Open, Non-Comparative Study of Fluconazole in Patients With Coccidioidal Meningitis
- Conditions
- MeningitisHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00002010
- Locations
- 🇺🇸
HIV Research Group, San Diego, California, United States
🇺🇸Tucson Veterans Administration Med Ctr, Tucson, Arizona, United States
🇺🇸Audie L Murphy Veterans Administration Hosp, San Antonio, Texas, United States
An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS)
- Conditions
- Mycobacterium Avium-Intracellulare InfectionHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00002090
- Locations
- 🇺🇸
Beth Israel Hosp, Boston, Massachusetts, United States
🇺🇸Audie L Murphy Veterans Administration Hosp, San Antonio, Texas, United States
🇺🇸Ohio State Univ Hosp, Columbus, Ohio, United States
Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy
- Conditions
- CandidiasisMycosesHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00002038
- Locations
- 🇺🇸
Pfizer Central Research, Groton, Connecticut, United States
A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy
- Conditions
- Mycobacterium Avium-Intracellulare InfectionHIV InfectionsTuberculosis, Mycobacterium Infection
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00002085
- Locations
- 🇺🇸
Natl Cancer Institute / Metabolism Branch, Bethesda, Maryland, United States
🇺🇸Pfizer Central Research, Groton, Connecticut, United States
A Study of Azithromycin in the Prevention of Mycobacterium Avium Complex Disease (MAC) in HIV-Infected Patients
- Conditions
- Mycobacterium Avium-Intracellulare InfectionHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00002309
- Locations
- 🇺🇸
United States Air Force Med Ctr, Lackland Air Force Base, Texas, United States
🇺🇸San Diego Naval Hosp, San Diego, California, United States
🇺🇸Womack Army Med Ctr / Med Clinic, Fort Bragg, North Carolina, United States
Azithromycin in the Treatment of Cryptosporidiosis in Patients Who Have Not Had Success With Other Drugs
- Conditions
- CryptosporidiosisHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00002328
- Locations
- 🇺🇸
Pfizer Central Research, Groton, Connecticut, United States